SARS-CoV-2 Influenza A&B Antigen Rapid Test

The SARS-CoV-2 Influenza A&B Antigen Rapid Test is a medical consumable that utilizes a lateral flow immunoassay to detect antigens of the SARS-CoV-2 virus, as well as the Influenza A and B viruses, in nasal swab specimens.

Materials commonly used: The test kit includes a test cassette, a dropper, a buffer solution, and a disposable swab. The cassette has a membrane that is coated with monoclonal antibodies against SARS-CoV-2, Influenza A, and Influenza B antigens.

Common specifications: The SARS-CoV-2 Influenza A&B Antigen Rapid Test has a sensitivity of 96.4% for detecting SARS-CoV-2 antigens and 93.3% for Influenza A&B antigens, with a specificity of 98.5% for SARS-CoV-2 and 99.0% for Influenza A&B. The test can provide results within 15 minutes and has a shelf life of 24 months when stored at 2-30°C.

Application scenarios and fields of application: The SARS-CoV-2 Influenza A&B Antigen Rapid Test is suitable for use in various settings, including hospitals, clinics, and community testing centers. It can be used for the rapid screening of patients with suspected SARS-CoV-2 or Influenza A&B infections, especially in areas with high disease prevalence or limited laboratory testing resources.